Ro5-3335
Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation[1].
Product Specifications
CAS Number
[30195-30-3]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
RUNX
Type
Reference compound
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ro5-3335.html
Purity
99.52
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1NC2=CC=C(Cl)C=C2C(C3=CC=CN3)=NC1
Molecular Formula
C13H10ClN3O
Molecular Weight
259.69
Precautions
H302, H315, H319, H335
References & Citations
[1]Cunningham L, et al. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction. Proc Natl Acad Sci U S A. 2012 Sep 4;109 (36) :14592-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RUNX1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15101766 1 Vial
Lentiviral human GABPB2 shRNA (UAS) - Lentiviral human GABPB2 shRNA (UAS) (100)
Ask
View Details 
P9005-26J-HRP 100 µL
Procalcitonin (Calcitonin Precursor, Calcitonin Related Polypeptide alpha, Calcitonin-related Polypeptide alpha, CALC1, CGRP, CGRP1, CT, Katacalcin, KC, Preprocalcitonin) (HRP) discontinued
Ask
View Details